Application 040253

Type: ANDA
Sponsor: PHARM ASSOC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ETHOSUXIMIDE	ETHOSUXIMIDE	SYRUP;ORAL	250MG/5ML	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040253-001	ETHOSUXIMIDE	ETHOSUXIMIDE	250MG/5ML	SYRUP / ORAL	AA		2000-11-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A040253-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A040253-001	ETHOSUXIMIDE	250MG/5ML	SYRUP / ORAL	AA		2000-11-22	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A040253-001	AA	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ETHOSUXIMIDE	ETHOSUXIMIDE	PAI Holdings, LLC dba PAI Pharma	8a5cc930-0b36-48a8-9ad0-de633b208742	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040253 application number: ANDA040253 ndc (product): 0121-0670

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0121-0670	ETHOSUXIMIDE	ETHOSUXIMIDE	PAI Holdings, LLC	ANDA	Current
0121-0670	ETHOSUXIMIDE	ETHOSUXIMIDE	Pharmaceutical Associates, Inc.	ANDA	Current
0121-0670	ETHOSUXIMIDE	ETHOSUXIMIDE	Pharmaceutical Associates, Inc.	ANDA	Current
0121-0670	ETHOSUXIMIDE	ETHOSUXIMIDE	Pharmaceutical Associates, Inc.	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
38873	ORIG	2004-06-03
42600	ORIG	2003-07-31
7591	ORIG	2000-11-22